• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于稳定肥大细胞的纳米纤维涂层药物洗脱支架

Nanofiber-coated drug eluting stent for the stabilization of mast cells.

作者信息

Oh Byeongtaek, Lee Chi H

机构信息

Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, HSB-4242, Kansas City, Missouri, 64108, USA.

出版信息

Pharm Res. 2014 Sep;31(9):2463-78. doi: 10.1007/s11095-014-1341-3. Epub 2014 Mar 25.

DOI:10.1007/s11095-014-1341-3
PMID:24664448
Abstract

PURPOSE

The nanofiber-hydrogel blend containing nitric oxide (NO) donors and reactive oxygen species (ROS) scavengers (Edaravone: EDV) was explored as an advanced strategy for stabilization of Mast cells (MCs) to achieve efficient immune-suppressive effects.

METHODS

Three types of nanofiber hydrogel composites (Bare-Nanofibers (BNF), Nanofiber-Hydrogels (NF-Gel) and Cross-linked Nanofiber-Hydrogels (NF-Gel-X)), were evaluated. The degranulation rates of MCs were determined by measurement of the extracellular levels of hydrogen peroxide and the released amounts of β-hexosaminidase from the activated-MCs (a-MCs). In addition, the effects of EDV on the selective scavenging of the oxygen radicals and prevention of peroxynitrite formation were evaluated. The roles of a-MCs in re-endothelialization and viability of coronary artery endothelial cells (hPCAECs) were defined using alamar blue and LDH assay, respectively.

RESULTS

Each polymer matrix has unique morphological characteristics. The effects of EDV (~1.0 mM) on the production of NO were greatly influenced by the presence of superoxide or hydroxyl radicals. NF-G-X containing a mixture of EDV and S-Nitroglutathione (GSNO) produced the highest level of NO under the oxidative stress conditions. GSNO alone or a mixture of GSNO and EDV significantly lowered the degranulation rate of a-MCs (GSNO only: 55.8 ± 5.4%; GSNO with EDV: 50.6 ± 0.6%), indicating that NO plays an integral role in degranulation of a-MCs. There were no significant biochemical evidences of cytotoxic effects of GSNO and EDV on the hPCAECs.

CONCLUSIONS

Nanofibers containing a mixture of nitric oxide donors and ROS scavengers could be used as a promising strategy to stabilize MCs from the ROS-mediated immune responses.

摘要

目的

探索含有一氧化氮(NO)供体和活性氧(ROS)清除剂(依达拉奉:EDV)的纳米纤维-水凝胶混合物,作为稳定肥大细胞(MCs)以实现有效免疫抑制作用的先进策略。

方法

评估了三种类型的纳米纤维水凝胶复合材料(裸纳米纤维(BNF)、纳米纤维-水凝胶(NF-Gel)和交联纳米纤维-水凝胶(NF-Gel-X))。通过测量细胞外过氧化氢水平和活化肥大细胞(a-MCs)释放的β-己糖胺酶量来确定MCs的脱颗粒率。此外,评估了EDV对氧自由基的选择性清除和防止过氧亚硝酸盐形成的作用。分别使用alamar蓝和LDH测定法确定a-MCs在冠状动脉内皮细胞(hPCAECs)再内皮化和活力中的作用。

结果

每种聚合物基质都具有独特的形态特征。超氧化物或羟基自由基的存在极大地影响了EDV(~1.0 mM)对NO产生的影响。含有EDV和S-亚硝基谷胱甘肽(GSNO)混合物的NF-G-X在氧化应激条件下产生的NO水平最高。单独的GSNO或GSNO与EDV的混合物显著降低了a-MCs的脱颗粒率(仅GSNO:55.8±5.4%;GSNO与EDV:50.6±0.6%),表明NO在a-MCs的脱颗粒中起不可或缺的作用。没有显著的生化证据表明GSNO和EDV对hPCAECs有细胞毒性作用。

结论

含有一氧化氮供体和ROS清除剂混合物的纳米纤维可作为一种有前景的策略,用于稳定MCs免受ROS介导的免疫反应。

相似文献

1
Nanofiber-coated drug eluting stent for the stabilization of mast cells.用于稳定肥大细胞的纳米纤维涂层药物洗脱支架
Pharm Res. 2014 Sep;31(9):2463-78. doi: 10.1007/s11095-014-1341-3. Epub 2014 Mar 25.
2
Advanced cardiovascular stent coated with nanofiber.纳米纤维涂层的高级心血管支架。
Mol Pharm. 2013 Dec 2;10(12):4432-42. doi: 10.1021/mp400231p. Epub 2013 Nov 7.
3
A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.一种一氧化氮供体呋咱部分可提高依达拉奉对缺血/再灌注诱发的早期肾功能障碍和损伤的疗效。
Oxid Med Cell Longev. 2015;2015:804659. doi: 10.1155/2015/804659. Epub 2015 Mar 5.
4
Targeted delivery of NO donor and ROS scavenger for synergistic treatment of rheumatoid arthritis.靶向递呈一氧化氮供体和活性氧清除剂协同治疗类风湿关节炎。
Biomed Pharmacother. 2024 May;174:116540. doi: 10.1016/j.biopha.2024.116540. Epub 2024 Apr 4.
5
Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.依达拉奉是一种自由基清除剂,在体外和体内均能保护视网膜免受损伤。
J Pharmacol Exp Ther. 2009 May;329(2):687-98. doi: 10.1124/jpet.108.148676. Epub 2009 Feb 6.
6
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.用于临床的自由基清除剂依达拉奉可改善大鼠肾脏缺血/再灌注损伤。
Kidney Int. 2004 May;65(5):1714-23. doi: 10.1111/j.1523-1755.2004.00567.x.
7
Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.自由基清除剂依达拉奉抑制大鼠腹主动脉瘤的形成和发展。
J Vasc Surg. 2012 Jun;55(6):1749-58. doi: 10.1016/j.jvs.2011.11.059. Epub 2012 Feb 15.
8
Nitric oxide-induced apoptosis in cultured rat astrocytes: protection by edaravone, a radical scavenger.一氧化氮诱导培养的大鼠星形胶质细胞凋亡:自由基清除剂依达拉奉的保护作用
Glia. 2007 Oct;55(13):1325-33. doi: 10.1002/glia.20541.
9
Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier.用于间充质干细胞载体的仿生坚固水凝胶
Pharm Res. 2015 Oct;32(10):3213-27. doi: 10.1007/s11095-015-1698-y. Epub 2015 Apr 25.
10
Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability.依达拉奉包封的激动性胶束通过调节血脑屏障通透性挽救缺血性脑组织。
Theranostics. 2017 Feb 8;7(4):884-898. doi: 10.7150/thno.18219. eCollection 2017.

引用本文的文献

1
Advances in Nitric Oxide-Releasing Hydrogels for Biomedical Applications.用于生物医学应用的一氧化氮释放水凝胶的进展
Curr Opin Colloid Interface Sci. 2023 Aug;66. doi: 10.1016/j.cocis.2023.101704. Epub 2023 May 15.
2
Mast Cells as a Potential Target of Molecular Hydrogen in Regulating the Local Tissue Microenvironment.肥大细胞作为分子氢调节局部组织微环境的潜在靶点。
Pharmaceuticals (Basel). 2023 May 30;16(6):817. doi: 10.3390/ph16060817.
3
Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis.

本文引用的文献

1
Nanofiber for cardiovascular tissue engineering.用于心血管组织工程的纳米纤维。
Expert Opin Drug Deliv. 2013 Nov;10(11):1565-82. doi: 10.1517/17425247.2013.830608. Epub 2013 Sep 25.
2
Advanced cardiovascular stent coated with nanofiber.纳米纤维涂层的高级心血管支架。
Mol Pharm. 2013 Dec 2;10(12):4432-42. doi: 10.1021/mp400231p. Epub 2013 Nov 7.
3
Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology.当代覆膜支架的演进:临床应用、纳米技术材料和制造策略。
靶向铁死亡可减轻慢性前列腺炎中的炎症、纤维化和肥大细胞激活。
J Immunol Res. 2022 Jun 17;2022:6833867. doi: 10.1155/2022/6833867. eCollection 2022.
4
Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.纳米尺度的表面工程:提高冠状动脉支架疗效的前进之路。
APL Bioeng. 2021 Jun 1;5(2):021508. doi: 10.1063/5.0037298. eCollection 2021 Jun.
5
Computational Analysis on Down-Regulated Images of Macrophage Scavenger Receptor.巨噬细胞清道夫受体下调图像的计算分析。
Pharm Res. 2017 Oct;34(10):2066-2074. doi: 10.1007/s11095-017-2211-6. Epub 2017 Jun 26.
6
Development of Thiolated-Graphene Quantum Dots for Regulation of ROS in macrophages.巯基化石墨烯量子点调控巨噬细胞中 ROS 的研究进展。
Pharm Res. 2016 Nov;33(11):2736-47. doi: 10.1007/s11095-016-2000-7. Epub 2016 Jul 21.
7
Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier.用于间充质干细胞载体的仿生坚固水凝胶
Pharm Res. 2015 Oct;32(10):3213-27. doi: 10.1007/s11095-015-1698-y. Epub 2015 Apr 25.
Biotechnol Adv. 2013 Sep-Oct;31(5):524-42. doi: 10.1016/j.biotechadv.2012.12.010. Epub 2013 Jan 7.
4
Presence of hydrogen peroxide, a source of hydroxyl radicals, in acid electrolyzed water.酸性电解水中存在过氧化氢,是羟基自由基的来源。
PLoS One. 2012;7(9):e46392. doi: 10.1371/journal.pone.0046392. Epub 2012 Sep 28.
5
Optimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditions.优化心血管支架以防止再狭窄:基于因子设计的聚合物涂层条件统计分析。
PLoS One. 2012;7(8):e43100. doi: 10.1371/journal.pone.0043100. Epub 2012 Aug 22.
6
Reactive oxygen species: from health to disease.活性氧:从健康到疾病。
Swiss Med Wkly. 2012 Aug 17;142:w13659. doi: 10.4414/smw.2012.13659. eCollection 2012.
7
Mast cell degranulation mediates compound 48/80-induced hyperalgesia in mice.肥大细胞脱颗粒介导化合物 48/80 诱导的小鼠痛觉过敏。
Biochem Biophys Res Commun. 2012 Aug 24;425(2):237-43. doi: 10.1016/j.bbrc.2012.07.074. Epub 2012 Jul 22.
8
Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia.基于一氧化氮和亚硝酸盐的内膜增生治疗机会。
Nitric Oxide. 2012 May 15;26(4):285-94. doi: 10.1016/j.niox.2012.03.014. Epub 2012 Apr 5.
9
Mitochondrial reactive oxygen species and risk of atherosclerosis.线粒体活性氧与动脉粥样硬化风险。
Curr Atheroscler Rep. 2012 Jun;14(3):264-76. doi: 10.1007/s11883-012-0237-0.
10
Advanced polymeric matrix for valvular complications.用于瓣膜并发症的先进聚合基质。
J Biomed Mater Res A. 2012 May;100(5):1151-9. doi: 10.1002/jbm.a.34055. Epub 2012 Feb 15.